Zonulin levels were significantly increased (p = 0.017) in MS patients’ samples (mean ± standard error: 27.13 ± 2.08 ng/mL) when compared with controls’ (mean ± standard error: 19.01 ± 2.98 pg/mL) (Figure 6A). This evidence concerns the gene HP and myeloid sarcoma.